GlassScriptPhysician profile
Gustavo Vargas
NPI 1396851002
$773.27
in general payments reported to CMS, 2019-2025
10 companies · $163 in 2025
The $163 reported for 2025 was more than what 86% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $236 · 2023: $112 · 2024: $122 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $440.29 | 2021-2025 | Workmate Claris, Gallant, Aveir |
| Merck Sharp & Dohme LLC | $85.65 | 2022-2025 | Bridion |
| Avanos Medical | $78.75 | 2022 | |
| Impulse Dynamics (USA) INC. | $47.00 | 2023-2024 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $31.11 | 2022-2024 | Xarelto |
| Vertex Pharmaceuticals Incorporated | $25.44 | 2024 | |
| Octapharma USA, INC. | $22.04 | 2025 | Fibryga |
| Pacira Pharmaceuticals Incorporated | $14.90 | 2022 | |
| Biotronik INC. | $14.40 | 2021 | |
| Boston Scientific Corporation | $13.69 | 2025 | Accolade Sr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gustavo Vargas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.